Professor Dame Molly Stevens is awarded the Novo Nordisk Prize

Professor Dame Molly Stevens is awarded the Novo Nordisk Prize

Congratulations to Professor Dame Molly Stevens for being honoured with the 2023 Novo Nordisk Prize at a celebratory event in London on the 21st of February. This prestigious award recognises her groundbreaking work in innovative bioengineering approaches aimed at addressing key challenges in regenerative medicine and biosensing.


Patrick Hughes, Professor Dame Carol Robinson, Professor Dame Molly Stevens, Diane Atkinson and DPAG Head of Department Professor David Paterson at the award ceremony


Awarded by the Novo Nordisk Foundation, the prize acknowledges active scientists who have made exceptional contributions to advancing medical science for the betterment of people’s lives. Accompanied by DKK 5 million, this accolade highlights Professor Stevens' significant impact on interdisciplinary research.

During the event, Molly Stevens shared her vision, stating, “Imagine a world where diseases such as cancer, malaria, and heart failure could be detected as simply, quickly, and cheaply as pregnancy is today. We are harnessing the power of nanomaterials to make this dream a reality. This work is inherently interdisciplinary, and I would like to thank my team and colleagues – a diverse cast of materials scientists, engineers, chemists, biologists, physicists, and surgeons. Everything we have achieved is a result of this fantastic team-based effort.”

Jørgen Frøkiær, Chair of the Novo Nordisk Prize Committee, also commended Professor Stevens, highlighting her pioneering discoveries in bioengineering to develop innovative materials-based solutions across regenerative medicine, biosensing, and therapeutics. He noted her focus on addressing difficult problems with great clinical impact, and emphasised her legacy of mentoring and guiding future researchers in the field.

Professor Stevens’ receipt of the Novo Nordisk Prize underscores her exceptional contributions to the scientific community and her dedication to advancing medical research for the benefit of society.